1. Home
  2. MAXN vs TCRX Comparison

MAXN vs TCRX Comparison

Compare MAXN & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maxeon Solar Technologies Ltd.

MAXN

Maxeon Solar Technologies Ltd.

HOLD

Current Price

$2.45

Market Cap

52.2M

Sector

Technology

ML Signal

HOLD

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

HOLD

Current Price

$1.04

Market Cap

57.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAXN
TCRX
Founded
2019
2018
Country
Singapore
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.2M
57.9M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
MAXN
TCRX
Price
$2.45
$1.04
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$8.50
AVG Volume (30 Days)
272.3K
443.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.18
EPS
N/A
N/A
Revenue
N/A
$2,816,000.00
Revenue This Year
$100.37
$286.83
Revenue Next Year
$24.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$0.88
52 Week High
$4.97
$2.57

Technical Indicators

Market Signals
Indicator
MAXN
TCRX
Relative Strength Index (RSI) 41.29 50.53
Support Level N/A $0.90
Resistance Level $3.63 $1.23
Average True Range (ATR) 0.20 0.07
MACD -0.02 0.01
Stochastic Oscillator 12.65 59.00

Price Performance

Historical Comparison
MAXN
TCRX

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, Italy, and Rest of world.

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Share on Social Networks: